These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33660005)

  • 21. Vaginal microflora following the use of a disposable home-use vaginal device and a commercially available ring pessary for pelvic organ prolapse management: a randomized controlled trial.
    Ziv E; Keller N; Erlich T
    Arch Gynecol Obstet; 2024 Feb; 309(2):571-579. PubMed ID: 37882871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
    Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
    Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
    Yang J; Han J; Zhu F; Wang Y
    Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal pessaries for pelvic organ prolapse and urinary incontinence: a multiprofessional survey of practice.
    Bugge C; Hagen S; Thakar R
    Int Urogynecol J; 2013 Jun; 24(6):1017-24. PubMed ID: 23179500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
    Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
    J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse.
    Clemons JL; Aguilar VC; Tillinghast TA; Jackson ND; Myers DL
    Am J Obstet Gynecol; 2004 Feb; 190(2):345-50. PubMed ID: 14981372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
    Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
    Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.
    Shayo BC; Masenga GG; Rasch V
    Int Urogynecol J; 2019 Aug; 30(8):1313-1321. PubMed ID: 30121703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pessaries on the vaginal microenvironment.
    Collins S; Beigi R; Mellen C; O'Sullivan D; Tulikangas P
    Am J Obstet Gynecol; 2015 Jan; 212(1):60.e1-6. PubMed ID: 25046810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of using pessaries for treatment of pelvic organ prolapse in rural Nepal.
    Robert M; Govan AJ; Lohani U; Uprety A
    Int J Gynaecol Obstet; 2017 Mar; 136(3):325-330. PubMed ID: 28099682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we define excess vaginal space? - Genital hiatus size and prolapse severity are correlated with cube pessary size.
    Nemeth Z; Farkas N; Farkas B
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():61-64. PubMed ID: 32791394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal Pessary for Pelvic Organ Prolapse: A French Multidisciplinary Survey.
    Pizzoferrato AC; Nyangoh-Timoh K; Martin-Lasnel M; Fauvet R; de Tayrac R; Villot A
    J Womens Health (Larchmt); 2022 Jun; 31(6):870-877. PubMed ID: 34569823
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
    Lekskulchai O; Wanichsetakul P
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.
    Fernando RJ; Thakar R; Sultan AH; Shah SM; Jones PW
    Obstet Gynecol; 2006 Jul; 108(1):93-9. PubMed ID: 16816061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
    Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The history and usage of the vaginal pessary: a review.
    Oliver R; Thakar R; Sultan AH
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):125-30. PubMed ID: 21255901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.